You are here

INCREASE 202:  An Open-label extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease (INCREASE RIN-PH-202)

IRB Protocol #: 1705018243

Overview: The purpose of this research study is to provide or continue to provide inhaled treprostinil to eligible subjects who participated in the RIN-PH-201 study.  This trial is funded by United Therapeutics.


Dr. Irina Sobol
Principle Investigator
Phone: (212) 746-2381

Melissa Ricketts, MSHS, CCRC
Research Coordinator
Phone: (212) 746-2698

Make an Appointment

(646) 962-5558

Weill Cornell Medicine
Division of Cardiology

520 East 70th Street
Starr 443
New York, NY 10021

1305 York Avenue, 8th Floor
New York, NY 10021